eli lilly retatrutide press release 2024 2025 produces up to 30.3% weight loss in Phase 3 trial A new clinical trial from
Description
Only for Brand Wegovy, Zepbound
TRIUMPH-2: Obesity with Type 2 Diabetes Co-primary obesity + glycemic endpoints in patients with both conditions
Tirzepatide acts on two hormone pathways (GLP-1 and GIP) and is FDA-approved
Top Brand Categories by GLP-1 Uplift GLP-1 users also show elevated interest in luxury and aspirational brands: Lincoln (+27.8 pp), Rolex (+25.4 pp), Mercedes-Benz (+25.3pp), and Royal Caribbean (+26.8 pp)
This method is preferred over intramuscular injections due to its ease of administration and reduced risk of impacting blood vessels or nerves
If you have nausea, constipation, fatigue, or other GLP-1 side effects, Potere Health MD provides ongoing support to help you adjust safely
